PALERMO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.734
EU - Europa 981
AS - Asia 741
AF - Africa 74
SA - Sud America 72
OC - Oceania 4
Totale 3.606
Nazione #
US - Stati Uniti d'America 1.713
IT - Italia 350
SG - Singapore 320
CN - Cina 283
SE - Svezia 194
DE - Germania 102
AT - Austria 84
BG - Bulgaria 67
BR - Brasile 61
HK - Hong Kong 48
RU - Federazione Russa 45
CI - Costa d'Avorio 43
GB - Regno Unito 32
VN - Vietnam 31
NL - Olanda 21
TR - Turchia 20
IN - India 17
PL - Polonia 17
SN - Senegal 15
FR - Francia 14
CA - Canada 12
FI - Finlandia 11
IE - Irlanda 10
ES - Italia 6
CZ - Repubblica Ceca 5
MX - Messico 5
NG - Nigeria 5
AU - Australia 4
LT - Lituania 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
AR - Argentina 3
BE - Belgio 3
EG - Egitto 3
IQ - Iraq 3
TW - Taiwan 3
UA - Ucraina 3
EC - Ecuador 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
LU - Lussemburgo 2
PA - Panama 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 3.606
Città #
Santa Clara 221
Fairfield 174
Ashburn 166
Chandler 165
Singapore 153
Shanghai 134
Woodbridge 115
Milan 82
Houston 77
Seattle 77
Vienna 76
New York 73
Wilmington 73
Sofia 67
Boardman 56
Frankfurt am Main 51
Hong Kong 47
Cambridge 46
Abidjan 43
Princeton 41
Florence 37
Lawrence 35
Pisa 35
Beijing 30
Serra 29
Medford 28
Ann Arbor 25
Guangzhou 22
Lucca 20
Bremen 17
Istanbul 17
Trieste 17
Warsaw 16
Dakar 15
Ogden 14
Rome 14
San Diego 13
Fuzhou 11
Boulder 10
London 10
La Spezia 9
Los Angeles 9
Nuremberg 9
Dong Ket 8
Montignoso 8
Helsinki 7
Des Moines 6
Ottawa 6
Palaia 6
San Francisco 6
Brno 5
Cascina 5
Lagos 5
Mexico City 5
Munich 5
Newcastle upon Tyne 5
São Paulo 5
Bristol 4
Dallas 4
Dublin 4
Galway 4
Hebei 4
Hyderabad 4
Massa E Cozzile 4
Norwalk 4
Quanzhou 4
Stockholm 4
Amsterdam 3
Baghdad 3
Brussels 3
Dearborn 3
Falkenstein 3
Harbin 3
Irvington 3
Jiaxing 3
Kochi 3
Kunming 3
Manacor 3
Montelupo Fiorentino 3
Moscow 3
Nanjing 3
Naples 3
Qingdao 3
Redwood City 3
Rho 3
Tashkent 3
Urbana 3
Washington 3
Agadir 2
Arvada 2
Barcelona 2
Burlington 2
Calgary 2
Canberra 2
Council Bluffs 2
Fortaleza 2
Genoa 2
Genova 2
Goiânia 2
Haikou 2
Totale 2.588
Nome #
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 145
Antipsychotic drugs in Huntington's disease 140
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 131
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 121
Advances in the pharmacotherapeutic management of dementia with Lewy bodies 117
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 117
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 112
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 112
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 108
Freezing of gait and dementia in parkinsonism: A retrospective case–control study 103
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 102
Impact of COVID-19 pandemic on cognition in Parkinson's disease 92
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome 91
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease 90
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study 86
null 86
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 85
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 81
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 79
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 72
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 72
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 71
Molecular Imaging of the Dopamine Transporter 70
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 69
Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy 68
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 66
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 66
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 65
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 65
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification 63
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 62
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies 57
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 53
Dopamine transporter imaging, current status of a potential biomarker: A comprehensive review 53
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 51
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 49
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall? 42
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy 39
Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson's Disease 37
Statins in Parkinson's Disease: Influence on Motor Progression 35
Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy 35
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients 32
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 31
Two cases of Huntington's disease unmasked by the COVID-19 pandemic 31
Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? 30
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 30
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism 29
Expanding Glucocerebrosidase Involvement in Neurodegeneration: D419H Mutation Causing Dementia with Lewy Bodies 28
Early Compensatory Mechanisms in LRRK2 Mutation Carriers 24
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 24
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson’s Disease: A Retrospective Study by Different Expert Centers 23
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease 23
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 21
Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis 18
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay 16
Essential tremor and cognitive impairment: who, how, and why 16
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 16
α-Synuclein in Parkinson's Disease: From Bench to Bedside 16
Family History in Parkinson's Disease: A National Cross-Sectional Study 15
Clues to Reshaping Anti-α-Synuclein Immunotherapy in Early Parkinson's Disease Patients 15
Diagnosis of hereditary ataxias: a real-world single center experience 14
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 12
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report 11
Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: Cornerstones for Alzheimer’s precision medicine and pharmacology 9
Commentary: Development of the Blood-Based Alzheimer's Disease Liquid Biopsy 7
Totale 3.749
Categoria #
all - tutte 15.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 0 0 0 0 36 34 11
2020/2021318 13 45 3 27 9 24 57 14 46 10 25 45
2021/2022350 8 7 5 13 59 47 12 14 30 22 28 105
2022/2023695 84 108 71 46 55 67 6 41 151 1 53 12
2023/2024564 45 49 46 32 75 140 30 12 5 9 50 71
2024/20251.313 23 71 53 113 161 208 186 104 258 136 0 0
Totale 3.749